药品注册申请号：205386
申请类型：ANDA (仿制药申请)
申请人：DR REDDYS LABS SA
申请人全名：DR REDDYS LABORATORIES SA
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG No No AB 2016/10/28 2016/10/28 Discontinued
002 MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG No No AB 2016/10/28 Discontinued
003 MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG No No AB 2016/10/28 Discontinued
004 MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG No No AB 2016/10/28 Discontinued
批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级；罕用药状态通知信、审评文件、说明书、包装标签备注
2016/10/28 ORIG-1（原始申请） Approval STANDARD
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级；罕用药状态通知信、审评文件、说明书、包装标签备注
2018/09/18 SUPPL-5（补充） Approval REMS - MODIFIED - D-N-A
2017/05/26 SUPPL-3（补充） Approval REMS-Modified
与本品相关的专利信息（来自FDA橙皮书Orange Book）
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
无
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
无
与本品治疗等效的药品
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:15MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019516 003 NDA MS CONTIN MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription Yes No AB 1989/09/12 PURDUE PHARMA LP
074862 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 1998/07/07 RHODES PHARMS
075295 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 1998/10/28 STRIDES PHARMA INTL
075407 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 2000/01/28 DAVA PHARMS INC
076412 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 2003/07/31 SPECGX LLC
078761 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 2012/05/11 SUN PHARM INDS LTD
203849 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Prescription No No AB 2015/04/06 ACTAVIS ELIZABETH
203602 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Discontinued No No AB 2015/12/16 NOVEL LABS INC
205386 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 15MG Discontinued No No AB 2016/10/28 DR REDDYS LABS SA
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:30MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019516 001 NDA MS CONTIN MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription Yes No AB 1987/05/29 PURDUE PHARMA LP
074862 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 1998/07/07 RHODES PHARMS
075295 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 1998/10/28 STRIDES PHARMA INTL
076412 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 2003/07/31 SPECGX LLC
078761 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 2012/05/11 SUN PHARM INDS LTD
203849 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 2015/04/06 ACTAVIS ELIZABETH
203602 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Discontinued No No AB 2015/12/16 NOVEL LABS INC
205386 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 30MG Discontinued No No AB 2016/10/28 DR REDDYS LABS SA
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:60MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019516 002 NDA MS CONTIN MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription Yes No AB 1988/04/08 PURDUE PHARMA LP
074862 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 1998/07/07 RHODES PHARMS
075295 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 1998/10/28 STRIDES PHARMA INTL
076412 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2003/07/31 SPECGX LLC
078761 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2012/05/11 SUN PHARM INDS LTD
203849 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2015/04/06 ACTAVIS ELIZABETH
203602 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Discontinued No No AB 2015/12/16 NOVEL LABS INC
205386 003 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 60MG Discontinued No No AB 2016/10/28 DR REDDYS LABS SA
>>>活性成分:MORPHINE SULFATE; 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL; 规格:100MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019516 004 NDA MS CONTIN MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription Yes Yes AB 1990/01/16 PURDUE PHARMA LP
074769 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription No No AB 1998/07/02 RHODES PHARMS
075295 004 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription No No AB 2000/09/15 STRIDES PHARMA INTL
076438 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription No No AB 2003/07/03 SPECGX LLC
078761 004 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription No No AB 2012/05/11 SUN PHARM INDS LTD
203849 004 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Prescription No No AB 2015/04/06 ACTAVIS ELIZABETH
203602 004 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Discontinued No No AB 2015/12/16 NOVEL LABS INC
205386 004 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET, EXTENDED RELEASE;ORAL 100MG Discontinued No No AB 2016/10/28 DR REDDYS LABS SA
更多信息
药品NDC数据与药品包装、标签说明书
参考引用1
参考引用2
©2006-2025 DrugFuture->U.S. FDA Drugs Database